+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
OAL

Oriental Aromatics Share Price

 

 

Oriental Aromatics live price: ₹315.15. It opened at ₹315 vs previous close ₹310; intraday high/low: ₹318/₹308. The 50 & 200 DMA stand at ₹313.96/₹311.46.

Oriental Aromatics Performance

  • Today's Low
  • ₹308
  • Today's High
  • ₹318
  • 52 Week Low
  • ₹228
  • 52 Week High
  • ₹422
  • Open Price₹315
  • Previous Close₹310
  • Volume10,319
  • 50 DMA₹313.96
  • 100 DMA₹305.86
  • 200 DMA₹311.46

Oriental Aromatics Chart

Investment Returns

  • Over 1 Month + 1.37%
  • Over 3 Month + 28.56%
  • Over 6 Month + 8.69%
  • Over 1 Year -14.84%

Smart Investing Starts Here Start SIP with Oriental Aromatics for Steady Growth!

Invest Now

Oriental Aromatics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 320.4
  • PEG Ratio
  • -3.5
  • Market Cap Cr
  • 1,061
  • P/B Ratio
  • 1.6
  • Average True Range
  • 15.12
  • EPS
  • 0.98
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 2.99
  • RSI
  • 46.51
  • MFI
  • 34.36

Latest Stock News Updates

Q4FY26 & FY26 Result Announced for Oriental Aromatics Ltd.

Specialty Chemicals company Oriental Aromatics announced Q4FY26 & FY26 results Consolidated Financial Highlights: Revenue from operations: Q4FY26: Rs 28,237.45 lakh compared to Rs 25,316.19 lakh in Q4FY25 (YoY increase of 11.54%). Compared to Q3FY26 (Rs 25,156.06 lakh), this reflects a QoQ increase of 12.25%. FY26: Rs 1,03,078.38 lakh compared to Rs 92,825.62 lakh in FY25 (YoY increase of 11.05%). Profit before tax: Q4FY26: Rs 733.42 lakh compared to Rs 365.57 lakh in Q4FY25 (YoY increase of 100.62%). Compared to Q3FY26 (loss of Rs 184.20 lakh), this reflects a positive QoQ turnaround. FY26: Rs 1,077.18 lakh compared to Rs 4,760.76 lakh in FY25 (YoY decrease of 77.37%). Profit after tax: Q4FY26: Rs 398.59 lakh compared to Rs 142.24 lakh in Q4FY25 (YoY increase of 180.23%). Compared to Q3FY26 (loss of Rs 191.80 lakh), this reflects a positive QoQ turnaround. FY26: Rs 331.01 lakh compared to Rs 3,432.83 lakh in FY25 (YoY decrease of 90.36%). Earnings per share (Basic & Diluted): Q4FY26: Rs 1.18 compared to Rs 0.42 in Q4FY25. Compared to Q3FY26 ((Rs 0.57)), this reflects a positive QoQ turnaround. FY26: Rs 0.98 compared to Rs 10.20 in FY25 (YoY decrease of 90.39%). Standalone Results: Revenue from operations: Q4FY26: Rs 27,935.15 lakh compared to Rs 25,287.75 lakh in Q4FY25 (YoY increase of 10.47%). Compared to Q3FY26 (Rs 25,202.80 lakh), this reflects a QoQ increase of 10.84%. FY26: Rs 1,02,557.39 lakh compared to Rs 92,797.18 lakh in FY25 (YoY increase of 10.52%). Profit before tax: Q4FY26: Rs 1,252.21 lakh compared to Rs 1,127.07 lakh in Q4FY25 (YoY increase of 11.10%). Compared to Q3FY26 (Rs 369.46 lakh), this reflects a QoQ increase of 238.93%. FY26: Rs 3,272.58 lakh compared to Rs 6,192.70 lakh in FY25 (YoY decrease of 47.15%). Profit after tax: Q4FY26: Rs 917.38 lakh compared to Rs 818.37 lakh in Q4FY25 (YoY increase of 12.10%). Compared to Q3FY26 (Rs 361.86 lakh), this reflects a QoQ increase of 153.53%. FY26: Rs 2,526.41 lakh compared to Rs 4,683.55 lakh in FY25 (YoY decrease of 46.06%). Earnings per share (Basic & Diluted): Q4FY26: Rs 2.73 compared to Rs 2.43 in Q4FY25. Compared to Q3FY26 (Rs 1.08), this reflects a QoQ increase of 152.78%. FY26: Rs 7.51 compared to Rs 13.92 in FY25 (YoY decrease of 46.05%). Business Highlights: Segment Performance: Fine Chemicals: The Group operates in a single reportable segment, "Fine Chemicals." Dividend: The Board recommended a final dividend of Rs 0.25 per Equity Share of face value Rs 5 each for the financial year ended March 31, 2026, subject to shareholder approval. Corporate Developments: Appointment: Mr. John Gloster was appointed as an Additional Director (Non-Executive, Independent) for a term of 5 years starting May 20, 2026. Resignation: Mr. Deepak Ramachandra resigned as a Non-Executive Independent Director, effective May 21, 2026. Auditors: Re-appointed M/s. R J Goel & Co. as Cost Auditors and M/s. Nangia Global Advisors LLP as Internal Auditors for the financial year 2026-27. Subsidiary Sale: During the year, the Company sold its entire shareholding in Capital India Home Loans Limited (August 11, 2025). Result PDF

Oriental Aromatics Results Earnings Call for Q3FY26

Conference Call with Oriental Aromatics Management and Analysts on Q3FY26 Performance and Outlook. Listen to the full earnings transcript.

Q3FY26 Quarterly Result Announced for Oriental Aromatics Ltd.

Specialty Chemicals company Oriental Aromatics announced Q3FY26 results Revenue from operations: Rs 2,516 million against Rs 2,226 million during Q3FY25, change 13%. EBITDA: Rs 132 million against Rs 2,000 million during Q3FY25, change -93%. EBITDA Margin: 5.25% for Q3FY26. PBT: Rs -18 million against Rs 99 million during Q3FY25, change -118%. PAT: Rs -19 million against Rs 71 million during Q3FY25, change -127%. PAT Margin: -0.76% for Q3FY26. EPS: Rs -0.57 for Q3FY26. Result PDF

Oriental Aromatics Financials

Oriental Aromatics Technicals

EMA & SMA

Current Price
₹315.15
+ 5.65 (1.83%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹321.60
  • 50 Day
  • ₹314.00
  • 100 Day
  • ₹305.90
  • 200 Day
  • ₹311.50

Resistance and Support

313.75 Pivot Speed
  • R3 328.55
  • R2 323.15
  • R1 319.15
  • S1 309.75
  • S2 304.35
  • S3 300.35

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Oriental Aromatics Ltd. manufactures and supplies a wide range of fragrances, flavors, and aroma chemicals. The company operates state-of-the-art facilities in India, serving industries such as personal care, home care, food, and beverages both domestically and internationally.

Oriental Aromatics has an operating revenue of Rs. 1,030.78 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -9% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 31 which is a POOR score indicating inconsistency in earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at D which indicates heavy supply, Group Rank of 117 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Oriental Aromatics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-20 Audited Results & Final Dividend
2026-02-12 Quarterly Results
2025-11-10 Quarterly Results
2025-08-08 Quarterly Results
2025-05-27 Audited Results & Final Dividend
Date Purpose Remarks
2025-08-08 FINAL Rs.0.50 per share(10%)Final Dividend
2021-12-10 INTERIM Rs.1.50 per share(30%)Interim Dividend
View Oriental Aromatics Dividend History Arrow

Oriental Aromatics Shareholding Pattern

74.17%
0%
0%
19.06%
6.77%

Oriental Aromatics FAQs

Oriental Aromatics share price is ₹315 As on 04 July, 2026 | 15:27

The Market Cap of Oriental Aromatics is ₹1060.6 Cr As on 04 July, 2026 | 15:27

The P/E ratio of Oriental Aromatics is 320.4 As on 04 July, 2026 | 15:27

The PB ratio of Oriental Aromatics is 1.6 As on 04 July, 2026 | 15:27

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23